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Johne’s disease, caused by Mycobacterium avium subspecies paratuberculosis (MAP),
is a severe chronic enteritis which affects large populations of ruminants globally.
Prevention strategies to combat the spread of Johne’s disease among cattle herds
involve adhering to strict calving practices to ensure young susceptible animals do not
come in contact with MAP-contaminated colostrum, milk, or fecal material. Unfortunately,
the current vaccination options available are associated with high cost and suboptimal
efficacy. To more successfully combat the spread of Johne’s disease to young calves, an
efficient method of protection is needed. In this study, we examined passive immunization
as a mode of introducing protective antibodies against MAP to prevent the passage of
the bacterium to young animals via colostrum and milk. Utilizing the infectious MAP
phenotype developed after bacterial exposure to milk, we demonstrate that in vitro
opsonization with serum from Johne’s-positive cattle results in enhanced translocation
across a bovine MDBK polarized epithelial cell monolayer. Furthermore, immune serum
opsonization of MAP results in a rapid host cell-mediated killing by bovine macrophages
in an oxidative-, nitrosative-, and extracellular DNA trap-independent manner. This study
illustrates that antibody opsonization of MAP expressing an infectious phenotype leads
to the killing of the bacterium during the initial stage of macrophage infection.
Keywords: M. avium paratuberculosis, invasion, intestinal tract, antibodies, macrophage killing
Introduction
Johne’s disease is a chronic enteritis caused by the pathogen Mycobacterium avium subspecies
paratuberculosis (MAP). The global burden of the disease is widespread and outdated studies
suggest that the disease results in an economic loss of $250 million to $1.5 billion per year in culled
herds and loss of milk production within the US dairy industry alone (Stabel, 1998; Ott et al., 1999).
The most successful of current prevention strategies involves managing the spread of disease by
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implementing carefully planned calving practices to ensure that
young animals receive colostrum and milk from Johne’s-free
dams. These practices prevent the exposure of young susceptible
animals to contaminated feces, decrease the rate at which animals
are culled and removed from the herd after testing positive for the
bacterium.
Multiple vaccine formulations exist, though only one is
commercially available in the United States. Overall, vaccination
rates are generally low and herd-management is the most
common and economically feasible form of Johne’s prevention
worldwide. Published studies, and the product information
for the commercially available vaccine Mycopar (Boehringer
Ingelheim Vetmedica, Inc.) explain that while vaccination limits
the progression of cases to the clinical stage of the disease, it does
not prevent shedding of MAP in the feces, nor does it prevent
vaccinated animals from becoming infected (Wentink et al.,
1994). Due to these factors and its associated cost, strict timeline
of administration, and suboptimal efficacy, there is a continuous
push to develop more efficacious vaccines to combat MAP
infection. Unfortunately, the results obtained from the pipeline
of determining host toxicity and vaccine efficacy from in vitro
cultures and mouse models did not translate in a successful
vaccine trial in ruminant hosts due to unappreciated differences
in immunity and pathogenesis of the infection between animal
species (Hines et al., 2014). Furthermore, the phenotypic changes
that occur within MAP during infection (Everman et al., 2015)
or during exposure to different environmental or host reservoirs
(Cirillo et al., 1997; Patel et al., 2006; Alonso-Hearn et al.,
2010) may result in ineffective vaccine efficacy. It is possible
that due to the incorrect focus of vaccine development, chosen
vaccine candidates are not representative of the most relevant
antigens during the stages of Johne’s disease in the animal. This
is certainly a limitation of the current vaccine target approach,
with consequent inefficient protection over the full course of the
disease.
Compared to vaccine-induced (active) immunity, which
requires the host immune system to mount a response to
introduced antigens, passive immunity provides immediate
protection in the form of pre-formed antibodies. Neonatal
calves have a narrow repertoire of gammaglobulins due to
their immature immune systems and early protection of the
animal is provided by uptake of maternal immunoglobulins
concentrated in the colostrum during the first feedings in the
early hours of life. These colostrum-delivered antibodies provide
immediate immunity against naturally occurring enteric and
respiratory pathogens which can lead to deadly diarrheal and
pneumonic diseases in animals that do not receive proper
feedings of colostrum (Godden, 2008). Experimental vaccination
of pregnant cows has shown to provide protection against
pathogens such as Escherichia coli (Reiter and Brock, 1975; Nagy,
1980), Cryptosporidium parvum (Perryman et al., 1999), and
rotavirus (Saif et al., 1983), by the resulting mounted antibody
titers which are passed to the neonate during initial feedings of
colostrum. This passive transfer of opsonizing antibodies enables
host phagocytes to eliminate potentially harmful pathogens
by phagocytosis and intracellular killing, or by triggering
antibody-dependent cell-mediated cytotoxicity (ADCC) for the
elimination of the pathogen in the mucosal tissues of young
animals.
Previous studies have shown that MAP can reside within and
acquire an infectious phenotype in the presence of milk, and
in the mammary gland, with significant alteration in the gene
expression of the pathogen (Koenig et al., 1993; Patel et al., 2006;
Antognoli et al., 2008; Alonso-Hearn et al., 2010). This infectious
phenotype may provide a novel and unstudied array of surface
antigen biomarkers that may be used for the development of
more effective preventative strategies. Considering the inherent
susceptibility of young animals to infection, the altered and
infectious MAP phenotypes from milk exposure, the protective
mechanisms of passively obtained immunoglobulins, and the
knowledge that young calves are at the highest risk of acquiring
infection from uptake of contaminated milk, we hypothesize that
maternal passive immunity may serve as a protective mechanism
against the passage of MAP to young animals.
In the current study, we investigate the role of serum
opsonization and its effect on the bacterial interaction with
bovine epithelial cells and macrophages during infection. We
reveal that serum opsonization of the infectious phenotype
of MAP enhances the translocation of the bacteria across an
epithelial barrier. Upon interaction with bovine macrophages,
the immune serum opsonized pathogen expressing the milk-
exposed infectious phenotype is rapidly killed. Based on our
findings, we begin to understand how the method of passive
immunity delivered with the adult cows’ milk may serve as a
successful approach for protection against acquiring MAP in the
milk during the feeding of young animals.
Methods and Materials
Bacterial Culture
M. avium subspecies paratuberculosis strain K10 (ATCC BAA-
968) was cultured at 37◦C on 7H10 agar (BD; Franklin Lakes,
NJ) supplemented with casein hydrolysate (1 g/L; BD), 10%
(vol/vol) oleic acid, albumin, dextrose, and catalase (OADC;
Hardy Diagnostics; Santa Maria, CA), and ferric mycobactin J
(2 mg/L; Allied Monitor, Fayette, MO) for 3–4 weeks. Prior to
experiments, a bacterial suspension was made in HBSS (Corning;
Corning, NY), passed through a 22-gauge needle five times to
disperse clumps, and allowed to settle for 10min. The top half of
the inoculumwas used as a single-cell suspension for experiments
(Patel et al., 2006).
Mammalian Cell Culture
Madin–Darby Bovine Kidney (MDBK) epithelial cells (CCL-
22) and murine RAW 264.7 macrophage cultures (TIB-71)
were obtained from the American Type Culture Collection
(ATCC; Manassas, VA). Both cells lines were cultivated in
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented
with 10% heat-inactivated fetal bovine serum (FBS; Gemini Bio-
Products; West Sacramento, CA), at 37◦C in 5% CO2. The
SV40 mutagenized bovine macrophage cell line (BOMAC) was
a gift from the USDA and cultivated in RPMI-1640 (Corning)
supplemented with 10% heat-inactivated fetal bovine serum at
37◦C in 5% CO2 (Stabel and Stabel, 1995).
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Serum Samples
Bovine Serum. Serum samples that were positive and negative
for antibodies against MAP antigens, as determined by USDA
diagnostic ELISA and Western blot against whole cell MAP
lysates, were obtained from the USDA Sample Repository (Ames,
IA) (Table 1). Serum samples from 10 positive and 10 negative
animals were acquired, positive and negative samples were
pooled, and aliquots stored at -80◦C prior to use. Mouse serum.
Six-week old female C57BL/6 mice were purchased from Jackson
Laboratory (Bar Harbor, ME) and held under observation for 1
week prior to use. MAP was exposed to milk as described below
and whole MAP lysate was isolated by bead-beating bacteria
with 0.1mm glass beads in HBSS 5 times for 30 s in a Mini-
BeadBeater (Biospec Products; Bartlesville, OK) at a speed of
4800 oscillations/min. Protein lysate was cleared of intact cells
and cell wall debris by centrifugation at 9500 × g for 30min
at 4◦C and plated to confirm no viable bacteria existed in
the antigen preparation. Ten mice were pre-bled for control
non-immune serum prior to immunization on day 0. Animals
were injected subcutaneously with 0.1mg of MAP antigen in
incomplete Freund’s adjuvant (Sigma; St. Louis, MO) in three
dorsal administration sites on day 1 and with 50µg of MAP
antigen in incomplete Freund’s adjuvant in two dorsal sites every
2 weeks. Test-bleeds were conducted to confirm antibody titer
by Western blot analysis using a 1:5000 dilution of serum as the
primary antibody and detected using a goat anti-mouse IRdye800
secondary detection antibody as per manufacturer’s instructions
(Licor; Lincoln, NE). Blood was collected via cardiac puncture
and serum was isolated by centrifugation at 5500 × g for 15min
at 4◦C. Samples were pooled and aliquots stored at −80◦C. All
animal procedures were completed in strict accordance with
guidelines set by the institutional animal care and use committee
(Oregon State University Animal Care and Use Protocol #4490).
Bacterial Exposure to Raw Milk and Serum
Opsonization
Freshly collected whole milk from Holstein-Friesian cows was
collected from a bulk tank at the Oregon State University
Dairy Center. Milk was separated into three fractions by
centrifugation for 20min at 13,000 × g; milk fat (top layer)
and milk particulate (pellet) were discarded and raw milk
(middle fraction) was treated with polymyxin B (5µg/ml),
amphotericin (22µg/ml), carbenicillin (25µg/ml), and
trimethoprim (2.5µg/ml) overnight at 4◦C. Samples were
centrifuged again for 20min at 13,000 × g to pellet any
precipitated material, supernatant was collected, and aliquots
frozen at −20◦C. Prepared raw milk samples were inoculated
with MAP for 24 h at 37◦C with shaking at 200 rpm. To isolate
milk-exposed MAP, suspension was centrifuged at 2000 × g for
15min at 4◦C, and pellet was washed in HBSS twice for 10min
at 3500 × g at 4◦C. For in vitro opsonization experiments,
1.5× 107 milk-exposed MAP were mixed with a 1:50 dilution of
serum in 1ml total in HBSS and incubated for 1 h in a rotating
hybridization oven at 37◦C. Mock controls were incubated in an
identical manner in the absence of serum.
TABLE 1 | Serum samples and MAP detection via PCR, agar growth, and ELISA tests.
Accession number Date collected Shedding status Direct PCR Solid media (Avg CFU/Tube) Parachek ELISA
NEGATIVES
09-029155 11/9/2009 Negative Negative Negative 0.07
09-029155 11/9/2009 Negative Negative Negative 0.057
10-007776 2/17/2010 Negative Negative Negative 0.08
10-013528 3/19/2010 Negative Negative Negative 0.0535
10-013528 3/19/2010 Negative Negative Negative 0.0545
10-013528 3/19/2010 Negative Negative Negative 0.0735
10-013528 3/19/2010 Negative Negative Negative 0.0695
10-007776 2/17/2010 Negative Negative Negative 0.08
10-044414 9/30/2010 Negative Negative Negative −0.021
10-044414 9/30/2010 Negative Negative ND −0.024
POSITIVES
NA 2/13/2007 High ND TNTC 3.095
NA 6/20/2007 High ND TNTC 2.439
548443 Apr-08 Low 30.7 6 1.03
547344 Apr-08 High 20.1 TNTC 2.2175
547344 Apr-08 High 23.8 TNTC 1.6765
09-012862 Aug-09 High 30.0 300 1.311
10-036633 Jul-10 High 22 4900 1.84
11-056306 11/7/2011 High 27.5 317.5 2.176
12-003868 2/1/2012 High 28.3 517.5 2.965
12-005807 2/15/2012 High 28.9 8500 1.511
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Invasion Assays
MDBK, BOMAC, or RAW 264.7 cells were seeded into 48-well
plates and grown to 80% confluence prior to experiments.
Cells were infected at an MOI of 10:1 with opsonized MAP
samples and controls in complete DMEMor RPMI and infections
were synchronized at 220 × g for 5min prior to incubation
at 37◦C with 5% CO2. For invasion assays, infections were
incubated for 15, 30, 45min or 1 h depending on experimental
design, cells were washed three times with HBSS and depending
on experiment, fresh DMEM supplemented with amikacin
(200µg/ml) was added to each well for 2 h to kill extracellular
bacteria and washed 3 times with HBSS prior to lysis (Bermudez
and Young, 1994). To quantify bacterial uptake cells were lysed
with 0.1% triton X-100 in deionized water, samples collected,
serially diluted, and plated for CFU determination.
Transwell Monolayer Translocation Assays
A transwell insert (Costar; Tewksbury, MA) with 3.0mm pores
was inserted into a 24-well tissue culture plate (Corning). 104
MDBK cells/well were added to the apical chamber of each well
and DMEM was supplemented into the basal chamber upon
seeding. Both apical and basal chamber media was replenished
with fresh media every other day. The integrity of the monolayers
was measured every 2 days by two different methods: Trypan
Blue permeability and transmembrane resistance. Every 2 days,
0.4% trypan blue was added to the apical chamber of test
wells and basal chamber samples were collected at 1, 5, 10,
and 30min. Samples were measured for trypan blue absorbance
at 580 nm using a spectrophotometer (Boiadjieva et al., 1984;
Mangum et al., 1990). Transwell cultures were considered intact
monolayers and used for assays once the trypan blue permeability
read-out was less than OD580 0.010 at 30min post-exposure
and transmembrane resistance was greater than 400 /cm3
(Bermudez et al., 2002). For translocation assay, MAP was
exposed to milk and opsonized as described above. Transwell
inserts were infected with 106 MAP/well in the apical chamber
in DMEM and fresh media was added to the basal chamber
and incubated at 37◦C in 5% CO2. Samples were obtained at
6- and 24-h post-infection by collecting 500µl from the basal
chamber, at which time media was replaced with equal volume
media which was collected at 24 h post-infection. Data from 6-h
samples were obtained from direct quantification of colonies and
24-h samples were obtained by the addition of samples quantified
from both the 6- and 24-h timepoints.
Mammalian Cell Response Inhibitor Assays
To block cellular response mechanisms, cells were treated with
10 U/ml catalase (Sigma), 300 U/ml superoxide dismutase
(Sigma), a combination of 10 U/ml catalase and 300 U/ml
superoxide dismutase, 50µM diphenyleneiodonium chloride
(DPI; Sigma), 250µM NG-monomethyl-L-arginine (L-NMMA
monoacetate; ENZO Life Sciences; Farmingdale, NY), DNase
I 100 U/ml (Roche; Basel, Switzerland) and their respective
buffers of 0.1M potassium phosphate (catalase and superoxide
dismutase separately), 0.2M potassium phosphate (mix of
catalase/superoxide dismutase), dimethylsulfoxide (DMSO;
Sigma; used for DPI buffer), deionized water (L-NMMA),
and DNase Buffer alone (DNase) as previously described (De
Assis et al., 2000; Brinkmann et al., 2004; Aulik et al., 2012).
Host cells were incubated for 30min with each compound
or buffer in RPMI and washed two times with HBSS prior to
bacterial infection. Cells were then infected as described above
with opsonization samples suspended in RPMI supplemented
with each inhibitor or buffer for 15min, washed, lysed with
0.1% triton X-100 in deionized water, serially diluted, and
plated for CFU. Milk-exposed opsonized MAP samples and
host cells were incubated in cellular inhibitors individually
for the same amount of time to determine the effect of each
inhibitor on bacterial viability and host cell viability and
quantified using CFU counts or trypan blue staining (0.4% w/v),
respectively.
Statistical Analysis and Data Interpretation
Results are reported as the mean of at least 2 replicate
experiments each performed in triplicate ± standard error.
Statistical comparisons between experimental groups and control
groups were determined using the Student’s t-test with p <
0.05 denoting statistical significance. GraphPad Prism version
6.0 software was used for the construction of graphs, data
interpretation, and statistical analysis. The data presented in this
manuscript is determined by the CFU of MAP recovered from
the intracellular or extracellular environment (dependent on the
experiment) divided by the original CFU amount of bacteria
added to each well prior to infection. This value is thenmultiplied
by 100 to reach the percent uptake/survival/recovery as reported
in the graphs. To clarify the data, 4 vs. 6% uptake means that
4% of the original inoculum was recovered as intracellular CFU
data compared to 6% of the inoculum of the second sample. We
present our data in this manner to normalize for the variation in
inocula within each well, sample, and treatment type. However,
we do ensure that the original inocula are relatively close, making
sure the opsonization or chemical treatment of the bacteria isn’t
affecting the initial infecting inocula prior to experiments (data
not shown).
Results
Whole Serum Opsonization Influences the
Interaction of MAP with MDBK Epithelial Cells
Opsonization aids in the uptake of pathogens by host phagocytes
and has been demonstrated to enhance killing of intracellular
pathogens during infection (Weber et al., 2014). Previous
investigations have shown that opsonization of plate-grown
MAP increases the efficiency at which the bacterium is able
to be ingested and increases survival within the intracellular
compartment (Hostetter et al., 2005). However, the effect
opsonization has on the uptake of MAP by the intestinal mucosa
is unknown. To determine the effect of opsonization on the
interaction between MAP cultured in milk (hereafter referred to
as the infectious phenotype) and the bovine intestinal epithelium,
we evaluated how opsonization influenced the invasion of and
the translocation across polarized bovine MDBK epithelial cells.
The infectious phenotype of MAP was recovered and opsonized
with PBS (mock), pooled bovine serum from Johne’s negative
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animals (non-immune serum), or pooled bovine serum from
Johne’s positive animals (immune serum) (Table 1). Invasion
assays indicated that neither non-immune nor immune serum
opsonization had any significant effect on the ability of MAP
to invade MDBK epithelial cells compared to mock opsonized
samples (Figure 1).While the epithelial cell invasion capability of
MAP isn’t significantly affected by opsonization, the mechanism
of uptake may provide a difference in the survival or efficiency of
translocation across the epithelium.
To investigate the fate of opsonized MAP after uptake
by MDBK epithelial cells, a transwell culture assay was
employed. After 4 days in culture, monolayers were determined
to be impermeable and intact as demonstrated by both
transmembrane resistance measurements (Figure 2A) and a
trypan blue permeability assay performed 4 days after cell seeding
(Figure 2B). Opsonization with immune serum resulted in
enhanced translocation ofMAP across an intact polarizedMDBK
epithelial cell monolayer with 3.1-fold more bacteria being
recovered from the basolateral chamber after 6 h, and a 3.7-fold
increase in recovered MAP after 24 h post-infection compared
to non-immune serum opsonized bacteria (Figure 2C). These
data indicate that opsonization with sera from Johne’s infected,
immune positive cattle has little effect on uptake of bacteria
by MDBK epithelial cells, but results in significantly enhanced
translocation of infectious MAP across the polarized epithelial
cell monolayer during infection.
Bovine Macrophage Uptake of Serum Opsonized
MAP
Once established that opsonization of MAP increased the
level of translocation across a polarized MDBK epithelial
cell monolayer, we wanted to address whether enhanced
translocation contributes to the virulence of MAP by
allowing greater numbers to be taken up by and survive
FIGURE 1 | Effect of opsonization of milk-exposed MAP on invasion of
MDBK epithelial cells. MAP incubated in raw milk for 24 h was isolated and
opsonized in PBS (mock), or 2% serum from uninfected (non-immune), or
infected (immune) cattle for 1 h at 37◦C. MDBK monolayers were infected for
1 h at 37◦C before collection of cell lysate. Percent uptake was calculated by
(amount of intracellular bacteria/amount of bacteria added to the well) × 100.
Data represents mean ± SEM of two independent experiments each
performed in triplicate. Differences not significant (p > 0.05) as determined by
a Student’s t-test.
within tissue macrophages, or whether greater translocation
results in enhanced uptake and subsequent killing of MAP by
macrophages. To assess the MAP-macrophage interaction in
this system, we analyzed what effect opsonization had on the
uptake of MAP by an immortalized bovine macrophage cell line
(BOMAC). Preliminary assays were carried out to determine
if our experimental model was able to replicate the effect of
macrophage uptake of MAP grown under standard conditions
as previously described (Hostetter et al., 2005). Consistent with
previous studies, opsonization of broth cultured MAP with
serum samples results in a two-fold increase in uptake of MAP
by bovine macrophages after a 15min infection (Figure 3A). It
was also shown that neither mock (PBS), non-immune serum,
nor immune serum opsonization treatments of milk-cultured or
FIGURE 2 | Translocation of opsonized milk-exposed MAP across an
MDBK epithelial transwell monolayer. Apical chambers were seeded with
104 MDBK cells and monolayer integrity was measured. Trypan blue exclusion
assay was measured every other day (A), and transmembrane resistance of
each well was measured every day until monolayer resistance reached 400
/cm3 (B). MAP was incubated in milk for 24 h and then opsonized with PBS
(mock), serum from Johne’s negative cattle (non-immune serum), or pooled
serum from Johne’s positive cattle (immune serum). The apical chamber of
each transwell was infected with 106 MAP and samples from the basal
chamber were collected and quantified for translocated bacteria at 6 and 24 h
post-infection (C). Trypan blue permeability data represent mean ± SEM of
three independent experiments each performed in duplicate; transmembrane
resistance data represent mean ± SEM of eight wells and is representative of
three independent experiments; translocation data represent the mean ± SEM
of two independent experiments each performed in triplicate (*p < 0.05;
**p < 0.01; ***p < 0.001 as determined by a Student’s t-test).
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FIGURE 3 | Immune serum opsonization of milk-exposed MAP initiates
phenotype which decreases uptake of bacteria by BOMAC via
cell-mediated killing. MAP were incubated in 7H9 broth (A) or milk (B,C) for
24 h, then opsonized with non-immune serum, immune serum, or PBS (mock)
and used to infect BOMAC cells for 15min. Samples were immediately
collected and cell lysates (A,B) and supernatants (C) from each well were
quantified for bacterial uptake and supernatant bacterial viability, respectively.
Data shown represents the mean ± SEM of four independent experiments
each performed in triplicate (**p < 0.01, ***p < 0.001; ****p < 0.0001 as
determined by a Student’s t-test).
7H9-cultured MAP had any detrimental effect on the viability
of each pool of bacteria prior to infection (data not shown),
suggesting that any observable change is due to the response of
the host cell and not due to a difference of the initial inoculum
levels or from an impact on viability from serum components,
culture, or opsonization treatments occurring before
infection.
Prior studies demonstrated the increased ability of the
infectious phenotype of MAP to invade MDBK epithelial cells
(Patel et al., 2006), and our data indicates that the infectious
phenotype also has a significantly greater rate of uptake by
BOMAC cells after a 15min infection as 8.55 ± 1.15% of
MAP expressing the infectious phenotype are ingested by
BOMAC cells (Figure 3B; black bar) compared to 3.72 ± 0.32%
of 7H9-exposed MAP (Figure 3A; black bar) after infection
(p = 0.0054). To determine the effect of the infectious
phenotype on the interaction between opsonized MAP and
BOMAC cells, infection assays were carried out to assess the
amount bacteria that were able to be taken up by macrophages.
Intracellular bacterial quantification demonstrated that the
infectious phenotype resulting from milk exposure results in a
75% decrease in BOMAC uptake of immune serum opsonized
samples compared to mock or non-immune serum opsonized
MAP populations (Figure 3B). This decrease was observed over
a variety of infection lengths and sample treatments. Initial
3 h assays, which included a 1 h infection followed by 2 h of
antibiotic treatment, and short-term infections of 15min, 30min
and 1 h in the absence of antibiotic treatment were carried
out and result in nearly identical data (15min assay shown
in Figure 3B; other data not shown). Collectively, these data
indicate that immune serum opsonization of infectious MAP
results in a significant decrease in the amount of bacteria taken
up by BOMAC cell cultures during infection over both long- and
short-term infections.
Immunoglobulins in the serum, particularly IgG and IgA,
are responsible for opsonizing pathogens and toxins to enhance
uptake and subsequent killing, or for neutralization and
protection from disease, respectively (Janeway et al., 2001). To
ascertain which function the serum antibodies have in our model
and the mechanism responsible for the decrease in uptake of
immune serum opsonized MAP, the supernatant from each
experimental group during BOMAC cell infection was collected
and the number of viable bacteria quantified (Figure 3C). After
15min of infection approximately equal numbers of MAP were
recovered from the supernatant of mock, non-immune, and
immune serum opsonized infections. These findings indicate that
the decrease in uptake of MAP opsonized with immune serum
was not due to a neutralizing effect of the antibodies blocking
uptake by macrophages. Rather, the infectious phenotype
opsonized with immune serum results in the killing of MAP as
there is no difference in the viable amount of bacteria within
the supernatants of each treatment. The mechanism used to kill
immune serum opsonized bacteria is rapid, as significant changes
in viability occur after only a short 15min incubation period. In
total, these data illustrate that this infectious phenotype of MAP
serves as a key mechanism for recognition by immune serum
and for the specific response initiated by BOMAC cells during
infection.
Determining Macrophage Mechanisms for Killing
of Immune Serum Opsonized MAP
Innate cellular mechanisms are vital for allowing host cells to
react in a rapid and non-specific manner to pathogen associated
molecular patterns (PAMPs) (Medzhitov, 2001), as well as
antibody coated particles (Greenberg and Grinstein, 2002). The
phagocytic vacuole is hard-wired to fuse with lysosomes and
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deliver numerous oxidative stress molecules that eliminate the
pathogen within the vacuole (Janeway et al., 2001). To identify
which host cellular mechanism(s) are being employed in the
early killing of immune serum opsonized MAP, we inhibited
a variety of cellular mechanisms known to be utilized during
the process of phagocytosis. Though mycobacteria are well
described to inhibit this fusion process (Kuehnel et al., 2001;
Vergne et al., 2004), antibody-mediated phagocytosis may utilize
different vacuole trafficking signals and fusion mechanisms
which lead to a different outcome of mycobacterial survival.
Chemical inhibitors of classical oxidative mechanisms were
added to infections to determine if there was an effect on
the viability of opsonized and non-opsonized milk-exposed
MAP (Figure 4) over the course of the 15min infection. The
inhibition of hydrogen peroxide production by the addition of
catalase, and the blockage of superoxide anion radical efficacy
by superoxide dismutase (SOD) results in no change in the
recovery of immune serum opsonized populations of MAP. As
the conversion of superoxide by superoxide dismutase results in
the release of oxygen and hydrogen peroxide, to combat both
oxidative mechanisms we treated cells with a combination of
catalase and superoxide dismutase in tandem, which results in
no change from the control groups (Figure 4). The membrane
bound NADPH oxidase enzyme complex is responsible for
the production of a variety of reactive oxygen species (ROS)
including but not limited to peroxides, oxygen radicals, and
oxidative stress components that can kill bacteria within the cell
(Janeway et al., 2001). To antagonize the collective production
of these toxic products, cells were treated with the NADPH
oxidase inhibitor diphenyleneiodonium chloride (DPI). While
the overall levels of uptake were lower in DPI treated samples,
the overall pattern demonstrating a lower uptake of immune
serum opsonized MAP remains the same as with the addition
of other inhibitors. It was noted that DPI-treated MAP controls
result in a 35% decrease in the viability of the bacteria,
while there was a 10% decrease in host cell viability in DPI-
treated controls compared to DMSO vehicle treated samples,
accounting for the decrease in overall uptake in the DPI-treated
assays. All other controls demonstrate negligible changes in
viability of either MAP or host cell controls during treatment
with inhibitors or their respective vehicle controls (data not
shown).
In addition to the stimulation of an oxidative burst upon
phagocytosis, host cells can mount a nitrosative burst, specifically
by the production of nitric oxide, to aid in the destruction of
ingested pathogens. To analyze the role of nitric oxide during
phagocytosis of opsonized milk-exposed MAP, treatment was
completed with the nitric oxide inhibitor NG-monomethyl-L-
arginine (L-NMMA). Treatment with L-NMMA results in no
change in uptake and intracellular bacterial load of immune
serum opsonized MAP compared to control treated samples
(Figure 5). There was no effect on viability of the MAP or cell
FIGURE 4 | Inhibition of cellular killing mechanisms and effect on
uptake of opsonized MAP by BOMAC cells. BOMAC cultures were
pre-incubated in RPMI with the cellular mechanism inhibitors or respective
vehicle controls for 30min prior to infection as follows: catalase (10
U/ml)/0.2M potassium phosphate, superoxide dismutase (SOD; 300
U/ml)/0.2M potassium phosphate, diphenylene iodonium chloride (DPI;
50µM)/DMSO, a combination of catalase/SOD (10 and 300 U/ml,
respectively)/0.4M potassium phosphate buffer. Each well was infected with
107 mock, or serum opsonized milk-exposed MAP samples in RPMI in the
presence of each respective inhibitor/buffer combination or buffer alone.
After 15min incubation, samples were washed, lysed, and quantified. Data
shown represent mean ± SEM of two independent experiments each
performed in triplicate (Mock treated samples compared to immune serum
treated samples ****p < 0.0001, ***p < 0.001; Non-immune serum sample
treatment compared to immune serum treatment samples ++++p < 0.0001,
+++p < 0.001, ++p < 0.01 as determined by Student’s t-test).
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populations upon addition of L-NMMA in controls (data not
shown).
To identify if extracellular killing mechanisms were
responsible for the rapid killing of immune serum opsonized
MAP, we investigated the role of extracellular traps during our
infection model. Neutrophil extracellular traps (NETs) have been
described as a toxic tool employed upon infection with both
gram-negative and gram-positive organisms (Brinkmann et al.,
2004; Aulik et al., 2012). Upon exposure to stimuli, cells release
a sticky DNA net into the extracellular environment which is
characterized by the presence of histones and elastase enzymes.
This phenomenon has recently been reported to be used by
macrophages as well, resulting in macrophage extracellular traps
FIGURE 5 | Role of nitric oxide in the killing of immune serum
opsonized MAP during BOMAC infection. BOMAC cells were
pre-incubated with the cellular mechanism inhibitor L-NMMA (250µM) or
water vehicle control in RPMI medium for 30min prior to infection. Cells were
infected with 107 mock or serum opsonized milk-exposed MAP in RPMI in
the presence of inhibitor and buffer alone. After 15min infection, samples
were washed, lysed, and quantified. Data shown represent mean ± SEM of
two independent experiments each performed in triplicate (*p < 0.05,
**p < 0.01, ****p < 0.0001 as determined by Student’s t-test).
(METs) in response to TNF-α (Mohanan et al., 2013) and a
variety of pathogens and toxins (Aulik et al., 2012; Liu et al.,
2014). To determine if METs were stimulated in response to
infection with our bacterial populations, BOMAC cultures were
treated with DNase prior to and during each uptake assay. DNase
treatment identifies that the dissolution of DNA complexes
outside of the cell does not alter the pattern of selective immune-
serum opsonized MAP killing (Figure 6A), nor does it alleviate
the lack of extracellular immune serum opsonized MAP during
the assays (Figure 6B).
Opsonization of Infectious MAP Phenotype in a
Murine Model System
The observation that bovine macrophages were able to more
effectively eliminate the infectious phenotype of MAP after
opsonization with immune serum in such a rapid manner
has not previously been described prior to this study. To
understand if the phenomenon was specific to the physiology
of bovine macrophages or could be observed in other systems,
we completed the opsonization of the infectious phenotype of
MAP and infection in a murine model. We first produced
antibodies against the infectious phenotype of MAP in C57BL/6
mice. Western blot analysis of infectious MAP lysates and milk
protein alone confirm that collected mouse serum contained
antibodies which recognize only MAP bacterial lysate proteins
and not bovine milk proteins (Figure 7A). To identify the effect
the collected mouse serum had on the interaction of opsonized
infectious MAP with murine RAW 267.4 macrophages, we
conducted similar 15min macrophage infection assays as done
with the bovine model (Figures 7B,C). Murine RAW 264.7
macrophages exhibit a significantly lower level of immune
serum opsonized bacteria compared to non-immune serum
and mock opsonized samples (Figure 7B). Additionally, the
decrease in bacterial uptake by murine macrophages is not an
effect of neutralization, as the lack of intracellular MAP in
the uptake assays are not recovered from the supernatants of
FIGURE 6 | Role of macrophage extracellular traps (METs) in the
killing of immune serum opsonized MAP during BOMAC infection.
BOMAC cells were pre-incubated with DNase I/DNase buffer (100 U/ml)
or DNase buffer alone in RPMI medium for 30min prior to infection.
Cells were infected with 107 mock or serum opsonized milk-exposed
MAP in RPMI in the presence of inhibitor and buffer alone. After 15min,
infected cells were washed, lysed, and intracellular bacteria (A) and
bacteria-containing supernatant samples (B) were quantified. Data
shown represent mean ± SEM of two independent experiments each
performed in triplicate.
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FIGURE 7 | Effect of opsonization on MAP survival in a murine model.
Serum was collected from mice after subcutaneous vaccination with protein
preparations of the infectious phenotype of MAP over a 3 month timeframe.
Equal amounts of proteins from either the infectious MAP phenotype or milk
proteins only separated on an SDS-PAGE protein gel and Western blot was
conducted using terminal serum as the primary probing antibody (1:5000),
and probed with a goat α-mouse IR800 secondary antibody for visualization
(A). The infectious phenotype of MAP was opsonized with pre-bleed
non-immune serum, terminal bleed immune serum, or PBS (mock) and used
to infect RAW 264.7 macrophage cells for 15min. Cell lysate (B) and
supernatant (C) samples from each well were quantified for bacterial uptake
and supernatant bacterial viability, respectively. Data shown represents the
mean ± SEM of two experiments each performed in triplicate (**p < 0.01,
***p < 0.001 as determined by a Student’s t-test).
each culture (Figure 7C). These data validate that the pattern
of rapid host cell mediated killing is consistent between both
the bovine and murine in vitro model systems, and provides
further support that the infectious phenotype of MAP serves
as an important and relevant bacterial phenotype for studies
involving opsonization, and the resulting rapid phagocyte
killing, as a means of preventing infection in multiple species
models.
Discussion
At present, the most effective preventative measures against
Johne’s disease are strict calf management practices so as to avoid
the exposure of neonates and young animals to colostrum, milk,
feed, and soil contaminated with MAP. The currently approved
vaccine protocol involves administration of the bacterin within a
strict window between 0 and 30 days of age. Unfortunately, the
vaccine can be ineffective at stopping the spread of the disease
through a herd and results in variable protection against disease
depending on the immune status, age, infection status, and
other unknown factors about the animal. Treatment options are
difficult and not generally encouraged as they include antibiotic
regimens which are expensive, are required for the duration of
the animal’s life, and are often unable to fully eliminate the
infection. Most often, infected animals are culled in order to
prevent the transmission of MAP to the rest of the herd. Novel
vaccination strategies would allow for more successful methods
of preventing infection among young animals, thus slowing the
cycle of transmission and incidence of Johne’s disease within
herds.
The delivery of antibodies in colostrum and milk is an
important mechanism which passively transfers protective IgA
and IgG to neonatal and suckling animals that are born with
undeveloped and immature immune systems. The intestinal
physiology of neonatal calves is quite unique within the first
24 h of life as the animal needs to take up as much protective
immunoglobulin as it can to establish a protective immune
system. Neonatal animals express increased levels of the neonatal
Fc receptor (FcRn) in various tissues including the lung (Mayer
et al., 2004), and intestine (Kuo et al., 2010). These receptors
allow for the maximum level of absorption of maternal IgG
molecules into circulation for the establishment of immunity
and to provide local protection against pathogen exposure early
in life. Meanwhile, IgA molecules are utilized as neutralizing
protection against pathogens the young animal may encounter
prior to the establishment of a complete immune system. The
passive transfer of antibodies via milk from experimentally
vaccinated dams can result in protection against commonly
encountered farm pathogens (Reiter and Brock, 1975; Saif et al.,
1983; Perryman et al., 1999). In this study we aimed to identify
whether the shift to an infectious bacterial phenotype in milk
(Patel et al., 2006), its direct transmission to young animals
(Taylor et al., 1981; Sweeney et al., 1992), and the natural passage
of maternally-derived antibodies would be useful as a protective
mechanism against an intracellular pathogen such as MAP.
Our initial results suggest that antibodies do not play a
neutralizing role during initial epithelial cell infection as there
was no significant change in the invasion ability between
opsonized and mock treated MAP after 1 h of infection.
Alternatively, rather than protecting the epithelial barrier from
infection, opsonization of the infectiousMAP phenotype resulted
in a significantly increased rate of trafficking of MAP across an
intact polarizedMDBK epithelial cell transwell culture. Epithelial
cells, limited in their protective abilities, may be transporting
opsonized MAP to a location where they are more likely to
be appropriately dealt with by professional immune cells in
the mucosal tissue for a more successful and positive outcome
for the host. As MAP is an intracellular pathogen with an
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arsenal of mechanisms used to avoid host cell-mediated killing
mechanisms, we asked whether the enhanced translocation
across the epithelial cell layer was advantageous to the uptake by
and survival within host phagocytes, or whether it resulted in a
protective effect by triggering enhanced killing of the pathogen.
Astoundingly, upon opsonization of MAP expressing the milk-
induced infectious phenotype, the effect of opsonization changed
from one of enhanced uptake (Figure 3A) to one that resulted in
the immediately killing of the immune serum opsonized bacteria
(Figure 3B). This effect was solely a result of the phenotype
and antibody recognition, as preliminary experiments ruled
out reagent and protocol influence. The decrease in uptake of
immune serum opsonized MAP by macrophages was not an
effect of neutralizing IgA molecules, as we would have expected
to see a higher amount of unbound and non-phagocytized but
viable MAP in the supernatants to make up for the decrease in
intracellular MAP in each respective sample (Figures 3B,C). We
predict that the dramatic change in the outcome of opsonized
samples and the impact on MAP viability are an effect of the
specific milk-induced infectious bacterial phenotype and the
antibody recognition of serum from clinically infected cattle. The
more effective match between surface exposed biomarkers and
the deposition of antibodies during opsonization may be a key
factor in the development of a more specific, and here shown
as toxic, response by macrophages upon infection with immune
serum opsonized, milk delivered MAP. A limitation of our work
is that the system was only carried out using one type of bovine
epithelial cells (MDBK) and the results with other epithelia cell
type (such as bovine Mac-T mammary cell) could be different.
As we observed a rapid bacterial killing effect triggered by
immune serum opsonization of MAP, we focused on identifying
the specific innate immune mechanism responsible for the
bacterial killing in our model. Uptake of opsonized pathogens
results in the fusion of the bacteria-containing phagosome
with intracellular lysosomes containing bactericidal components.
The inhibition of the host cell-initiated mechanisms including
catalase, superoxide anions, and the functional NADPH oxidase
complex, resulted in no change in the viability of immune serum
opsonized MAP during the infection of bovine macrophages,
indicating that the oxidative burst triggered during uptake or
phagosome-lysosome fusion is not responsible for the rapid
killing of the bacteria (Figure 4). The nitrosative burst within
host phagocytes can also be used to eliminate intracellular
pathogens, although mycobacteria are described to inhibit
the recruitment of nitric oxide synthase to the phagosomal
membrane during macrophage infection (Miller et al., 2004), and
the level of nitric oxide produced during infection only results
in minimal mycobactericidal activity against MAP (Zhao et al.,
1997). Regardless of the role of nitric oxide during intracellular
MAP infection, inducible nitric oxide has been described to play
a role in the response to opsonized particles, as demonstrated by
luminescence assays in human macrophages (Gross et al., 1998);
though it has also been described that IgG-opsonized particles
induce apoptosis in macrophages in an oxidative-dependent
and nitric oxide-independent manner (Kim et al., 2003). We
illustrate that the inhibition of nitric oxide with L-NMMA
resulted in no change in the intracellular viability of opsonized
MAP in our model, indicating that the nitrosative burst is not
responsible for the killing of the immune serum opsonized MAP
upon macrophage infection. From these studies, we pinpoint a
variety of cellular mechanisms that are not responsible for the
killing of opsonized MAP. Further investigation into additional
mechanisms of cellular protection including Cu/Zn toxicity and
the activation of antibody-dependent cell-mediated cytotoxicity
and their role in killing of opsonized MAP will elucidate the
potential novel mechanism used to provide a toxic outcome for
MAP infection within our model.
As an extracellular mechanism for eliminating pathogens,
extracellular traps offer an efficient method of protection against
infection in a tissue. Themilieu that composes extracellular traps,
including histones, enzymes such as elastase and a variety of
cellular proteases, catch trap disease causing organisms, resulting
in their destruction and degradation. Our investigation shows
that the addition of DNase, which has the ability to disrupt the
DNA matrix formed in the traps, thus rendering them unable
to trap bacteria, has no effect on the killing on immune serum
opsonized MAP in our model system (Figure 6). Furthermore,
the formation of NETs is dependent on the ROS produced by
NADPH oxidase activity during infection (Fuchs et al., 2007).
Though it is unknown if the same is true for METs, the resulting
inhibition of NADPH oxidase with DPI in our study, which
shows no change in the host-mediated killing of immune serum
opsonized MAP, offers further evidence toward METs not being
the responsible cellular mechanism for the specific host-mediated
killing in our model.
It is important to address the current inability for protection
to be conferred to a neonate from a dam that is currently
infected with MAP and should, in theory, be providing
protective antibodies to her suckling calf. There are a variety of
physiological, molecular, and immunological reasons that may
explain why calves aren’t currently protected by the ingestion
of milk from an infected cow. It is quite possible that MAP-
contaminated milk does transfer both specific and non-specific
antibodies to the young calf which confers a certain level of
protection against MAP infection. Transferred antibodies may
provide a level of protection which increases the infectious dose
required for infection to be established, or it may simply allow
for a slower progression of the disease as fewer bacteria are
able to invade the epithelial lining in the beginning of infection.
It is also clear that MAP and the closely related M. avium
subspecies hominissuis readily change their phenotype based on
the environment they are in or the host they are infecting,
including milk (Patel et al., 2006), amoeba (Cirillo et al., 1997;
Tenant and Bermudez, 2006), bovine macrophages (Bermudez
et al., 2004; Patel et al., 2006), and intracellular passage between
epithelial cells and macrophages in the intestinal tissue. The
phenotype that a young animal is initially infected with, that
which is expressed by the bacterium as it begins to replicate and
spread throughout the host intestinal tissues, and the phenotype
that occurs upon the transition to the clinical, inflammatory stage
of the disease are potentially each characterized by their own
particular set of antigens that are different from one another.
Depending on the phenotype of the bacterium to which the
pregnant cow produced antibodies which would be naturally
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passed in the milk, it is possible that complete or even partial
protection may not be provided due to the mismatch between
the dominant antigen epitopes of the bacterium and the maternal
antibody recognition sites from her mounted humoral response.
Overall, little is known about the protection that maternal
antibodies delivered in colostrum and milk provide against MAP
infection, if it exists at all; though it is clear that full protective
passive immunity is not transferred as calves ultimately become
infected with MAP from early life feedings. As seen with other
pathogens (Reiter and Brock, 1975; Saif et al., 1983), it is a
possibility that the most protective antibody titers against MAP
would have to be induced by a vaccination with the relevant set
of infectious MAP antigens during pregnancy in order for the
production and adequate passage of protective antibodies to her
calf.
To further understand the effect of passively transferred
antibodies and the protective effect against MAP infection,
animal models must be employed. A mouse model would serve
as a simple in vivomodel to understand how the opsonization of
MAP affects the uptake of MAP by the intestinal enterocytes as
well as intestinal Peyer’s patches. Additionally, a mouse model
could further elucidate the role of tissue macrophages as well
as other intestinal innate immune cells and their respective
roles in the survival and/or killing of antibody-opsonized MAP
during infection. However, while mouse models would serve as
more simplified animal models to further study the mechanisms
described above, the neonatal calf would serve as the ideal animal
model. The uptake of colostrum and milk immunoglobulins is
dependent on the unique and specific physiology of the neonatal
calf. Antibodies are able tomore likely survive degradation due to
the lack of digestive enzymes such as pepsin which are secreted in
low amounts in the first hours of life (Thivend et al., 1980), and
only in the intestinal epithelium of newborn calves are antibodies
highly transported across the epithelial barrier which begins to
mature, divide, and set the appropriate intestinal acidic pH as
early as 12 h after birth (Stott et al., 1979; Kuo et al., 2010). Using
a neonate model would appropriately test the protective ability
of passive immunity and its effect in protecting against Johne’s
disease derived from MAP contaminated milk and colostrum
sources.
In total, we demonstrate that bacterial incubation with
serum containing opsonizing antibodies confers a protective
effect against the initiation of infection of MAP in bovine
and murine in vitro cell models. Opsonization of a relevant
infectious phenotype that is present at the immediate time of
passage from dam to calf results in greater translocation of
bacteria across polarized epithelial cells. Furthermore, additional
experiments demonstrate that rapid killing by macrophage-
mediated bactericidal mechanisms is employed by specifically
eliminating antibody-opsonized MAP. These data offer evidence
toward a novel preventative strategy that takes advantage of
the infectious phenotype that MAP expresses at the time of
transfer from cow to calf in the milk. The passive transfer
of anti-MAP antibodies and enhanced immunity in the early
hours of the life of a calf may be able to prevent the initiation
of disease in young animals, and thus stop infection and the
development and transmission of clinical Johne’s disease among
herds. Ongoing studies are identifying the specific antigens
in MAP associated with protection, and whether the same
antibody response in present in the milk. The results of these
studies can potentially help in the development of a mucosal
vaccine.
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